SEC Comment Letter for INVO Fertility, Inc. (IVF) (CIK 0001417926) (IVF) — Dec 26, 2018
INVO Fertility, Inc. (IVF) (CIK 0001417926)
Date: Dec. 26, 2018 · CIK: 0001417926 · Accession: 0000000000-18-039160
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228928
Letter
December 26, 2018 Kathleen T. Karloff Chief Executive Officer INVO Bioscience, Inc. 407 Rear Mystic Avenue, Suite 34C Medford, Massachusetts 02155 Re:INVO Bioscience, Inc. Registration Statement on Form S-1 Filed December 20, 2018 File No. 333-228928 Dear Ms. Karloff: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Michael Fay at 202-551-3812 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Scott Museles, Esq.
Show Raw Text
December 26, 2018
Kathleen T. Karloff
Chief Executive Officer
INVO Bioscience, Inc.
407 Rear Mystic Avenue, Suite 34C
Medford, Massachusetts 02155
Re:INVO Bioscience, Inc.
Registration Statement on Form S-1
Filed December 20, 2018
File No. 333-228928
Dear Ms. Karloff:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Fay at 202-551-3812 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Scott Museles, Esq.